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Abstract
Background: Cpf1 nucleases have recently been repurposed for site-specific genome modification. Two members
of the Cpf1 family, the AsCpf1 from Acidaminococcus sp. and the LbCpf1 from Lachnospiraceae bacterium were
shown to induce higher indel frequencies than SpCas9 when examining four randomly-selected target sequences
for each type of nuclease. Whether they are a real match for Cas9 nucleases, however, remains to be verified.
Results: Here, we used AsCpf1 and LbCpf1 to induce homology directed repair, either single strand annealing (SSA)
or homologous recombination (HR), in N2a mouse neuroblastoma cells. Exploiting a plasmid that contains two GFP
halves with overlapping sequences and exploring 20 targets, on all but one both nucleases consistently performed
with above 10 % efficiency. Several Cas9 nucleases have been previously characterised in order to find an
orthogonal counterpart for the most widely used promiscuous SpCas9. Here, we found that AsCpf1 and LbCpf1
might be better candidates than three of the best such counterparts: Cas9 from Staphylococcus aureus, from
Streptococcus thermophilus and from Neisseria meningitidis, when assessed for inducing efficient SSA mediated repair
in N2a cells. When tested on genomic targets exploiting HR, both nucleases were able to induce the integration of
a donor cassette with 1000 bp-long homologous arms. We also generated plasmids that express these Cpf1
nucleases together with their cognate crRNAs and that are equipped with type IIS restriction enzyme sites to
facilitate spacer cloning.
Conclusions: Our results suggest that employing As- or LbCpf1 nuclease to induce homology directed repair in
N2a cells, although is less effective at present than employing SpCas9, it is an equally or more effective tool than
the most frequently used orthogonal Cas9 counterparts of SpCas9. These findings support the position of Cpf1
nucleases on the side of SpCas9 on the palette of effective genome engineering tools.
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Background
Although recent studies suggest that clustered regularly
interspaced short palindromic repeat (CRISPR)-associ-
ated protein (Cas) systems are also used for non-defense
roles in the host [1, 2], they are best known as part of
the adaptive immune systems of prokaryotes that have re-
cently been exploited for generating extremely powerful
genetic devices [3–6]. The CRISPR-Cas system of the host
grants specific resistance against phages and plasmids by
keeping “memories” of past infections through acquiring
short DNA fragments and destroying the reinvading
agents that are identified based on these short, 20-30
nucleotide-long sequences [7, 8]. The adaptation modules
that acquire and deposit appropriate sequence motifs from
the invading agent to specific locations called CRISPR ar-
rays of the microbial genome, consist of two proteins:
Cas1 and Cas2 [9]. The effector complexes show much
greater diversity in terms of the participating Cas proteins,
across various prokaryotic CRISPR-Cas systems, and are
being divided into two classes: Class 1 systems that utilize
multiple subunit effector complexes, and Class 2 systems
that work with a single large effector Cas protein [10].
Within the two classes five types of complexes are being
distinguished (type I, III and IV of Class 1 and type II and
V of Class 2) according to the presence of one of the sig-
nature proteins: Cas3, Cas10, Csf1, Cas9, and Cpf1,
respectively [11–13]. Cas9 proteins, effectors of the type II
Class 2 systems have attracted particular attention in the
past few years due to their possible harnessing for genome
editing that quickly revolutionized the way we are capable
to execute site-specific modification of complex vertebrate
genomes today [3–5, 13, 14]. Cas9 proteins are also
exploited for the purpose to regulate transcription and
epigenetic states at specific genomic locations [15–22].
The power of Cas9 as a genome manipulating tool lays in
its easy programming. Altering the so called spacer
sequence of its associated RNA molecule – that deter-
mines the specificity of the nuclease – the Cas9 protein
can target different DNA sequences: i.e., those that con-
tain complementary sequences (protospacers) to the
chosen spacer sequence and also are immediately followed
by a short DNA motif called protospacer adjacent motif
(PAM). The PAM is recognized by the protein’s PAM-
binding domain and its sequence may differ for Cas9
proteins from different species [22, 23].
Recently, Cpf1 (CRISPR from Prevotella and Franci-
sella 1) nucleases – single effector proteins of the type V
Class 2 systems – have been investigated for their pos-
sible applicability for genome engineering tasks. Zetsche
et al. demonstrated that the Cpf1-containing CRISPR-
Cas locus of Francisella novicida U112 encodes a
functional defense system that is capable of mediating
plasmid interference in bacterial cells [24]. This work
revealed three features of Cpf1 of Francisella novicida
(FnCpf1) that seem to be general among Cpf1 nucleases
but are distinct from those of Cas9s. First, FnCpf1 works
with a single CRISPR RNA (crRNA) in contrast to Cas9
that also requires a trans-activating CRISPR RNA
(tracrRNA) for crRNA processing and target recognition
activity. Second, the PAM of FnCpf1 is rather T-rich in
contrast to the more G-rich Cas9 PAMs. Third, while
Cas9 nucleases produce blunt-end termini at double
strand breaks, FnCpf1 produces 4- or 5-nt-long 5’ over-
hangs [24]. Initially, Cpf1 nucleases were proposed to
act as dimers based on the fact that they contain only
one known nuclease domain (RuvC) and the inactivation
of this domain leads to a completely inactive Cpf1 in
contrast to Cas9 where the inactivation of one nuclease
domain generates a nickase [24]. However, it is not clear
how the concerted action of two, dimerized Cpf1
proteins might result in a double strand break. Recent
studies examining the crystal structure of one of the
Cpf1 nucleases, the Lachnospiraceae bacterium ND2006
Cpf1 (LbCpf1), and carrying out biophysical assays on
FnCpf1 showed that they display no oligomerisation
upon binding to crRNS and/or DNA [25, 26]. The
crystal structure of Acidaminococcus sp. BV3L6 Cpf1
(AsCpf1) reveals a nuclease domain with a new fold re-
sponsible for the cleavage of the target strand. Mutation
of the conserved residues of this domain abolishes the
double strand breaking activity of the nuclease, leading
to a nickase [27]. These distinct features of Cpf1 nucle-
ases might render them a very useful alternative genome
manipulating tool to Cas9s. This contention was further
strengthened by recent studies on the activity of Cpf1s on
off-target sequences [28–30]. Genome-wide off-target
analyses and targeted deep sequencing suggest that Cpf1
nucleases tolerate only one or two mismatches in contrast
to SpCas9 that has been reported to tolerate 5–6 mis-
matches [28–30].
Zetsche et al. examined 16 members of the Cpf1 nucle-
ase family. Two of them AsCpf1 and LbCpf1 were proved
to mediate efficient genome editing in HEK293FT cells. In
these experiments, exploring a limited set of four targets
and non-homologous end joining (NHEJ) repair, the indel
frequencies caused by AsCpf1 and LbCpf1 were actually
higher than that of SpCas9 [24].
Here, we investigated the activity of AsCpf1 and
LbCpf1 nucleases on a number of various targets in N2a
mouse neuroblastoma cells exploiting two homology
directed repair (HDR) pathways: single strand annealing
(SSA) and homologous recombination (HR), in contrast
to NHEJ repair, and compared their activity to various
Cas9 proteins.
Results
In order to monitor the activity of AsCpf1 and LbCpf1
nucleases we employed a fluorescence reporter assay
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using an interrupted-GFP expression cassette in a
plasmid where the two fragments (GFP “halves”) of the
GFP sequence are separated in a way to contain an over-
lapping 480 base-pairs long region (Additional file 1)
[31]. The target site for the nuclease is placed between
the two halves and upon nuclease cleavage the generated
double strand DNA break is repaired by single strand
annealing (SSA) directed by the overlapping homologous
sequences (Additional file 1). A presumably small frac-
tion of the breaks might also be repaired by homologous
recombination between two plasmids. The advantage of
this assay, that we refer to as “GFxFP assay”, is that it
allows measuring the ability of a nuclease to mediate
HDR by cleaving a specific target while the cleavage
efficiency is not influenced by factors like the epigenetic
state of the targeted locus or the relative distance of the
target from the homologous arms.
In order to test this assay system we used SpCas9 with
two targets that had been tested earlier in either mam-
malian (PrP10) or bacterial (Sp1) cells (unpublished
results). The interrupted GFP plasmids containing either
the Sp1 or the PrP10 target (see Additional file 2: Table
S1 for the target sequences) were cotransfected into N2a
mouse neuroblastoma cells with a vector expressing
SpCas9, the corresponding guideRNA (gRNA) and the
fluorescent protein iRFP670 [32]. The latter facilitated
monitoring of transfection efficiency. As control, a vector
expressing an inactive SpCas9 (dead, dSpCas9) was used
for transfecting the cells. The number of fluorescent cells
was counted two days after transfection. The Sp1 target re-
sulted in 73 %, while the PrP10 target resulted in 54 %
fluorescent cells in the transfected populations, respectively
(Additional file 1). Surprisingly, the control population also
showed a remarkable percentage, about 30 % GFP positive
cells (Additional file 1 – EGxxFP). Apparently, in a fraction
of the plasmids recombination between the homologous
sequences occurred without nuclease cleavage.
Next, to account for the possibility of recombination
events that may already take place in the bacterial cells
while handling the plasmid, either a chloramphenicol
resistance gene (pGF-chl-FP) or the plasmid replication
of origin (pGF-ori-FP) was placed within the region
between the homologous sequences of the GFP halves
(Fig. 1a). After plasmid isolation from bacterial cells we
found no indication of a recombined fraction occurring
in either of the cases (pGF-ori-FP and pGF-chl-FP
plasmids) when probed on agarose gel after restriction
enzyme digestions (data not shown). This suggests that
such a population, if exists, is less than 1 %. We cloned
the previously used Sp1 and PrP10 targets into these
vectors as well, and tested the SpCas9-induced repair of
GFP in N2a neuroblastoma cells. The insertion of the
chloramphenicol cassette resulted a decrease in the
number of the fluorescent cells in the active SpCas9
containing samples (Fig. 1b). When the inactive
dSpCas9-expressing vector was cotransfected with the
pGF-chl-FP plasmid, GFP positive cells could still be
detected, although at a lower percentage than in the case
of the unmodified original plasmid, EGxxFP (Fig. 1b).
This suggests that functional GFP molecules were still
expressed in a fraction of the pGF-chl-FP modified
plasmids without nuclease cleavage. The observed
decrease in the GFP signal may not only be attributable
to a reduction in the fraction of already recombined
plasmids in the bacterial cells, but might also reflect the
reduced recombination capability of the two GFP halves
as the distance between them is increased by the
presence of the chloramphenicol resistance cassette. The
origin of this relatively high background GFP fluores-
cence is not fully understood (Additional file 3), but it
may partially come from a somewhat high level of natur-
ally occurring double strand breaks present in N2a cells.
When comparing, anti-H2AX staining revealed that N2a
and HEK293T cells had rather comparable but remark-
ably higher levels of DNA double strand breaks than
HeLa cells (Additional file 3).
Since we observed that the detected fluorescence varied
from experiment to experiment (possibly reflecting the ac-
tual condition of the culture) but remained relatively
stable within the parallel transfections, here and in further
experiments we handled the samples to be compared in
parallel. Also, we subtracted the corresponding back-
ground fluorescence from each sample. We found similar
results with the pGF-ori-FP plasmid (data not shown) and
hereafter used this plasmid in further experiments.
AsCpf1 and LbCpf1 nucleases are more efficient when the
crRNAs are expressed from a plasmid rather than a
PCR-based template
To test the activity of AsCpf1 and LbCpf1 nucleases
employing the GFxFP assay we used the DNMT1.3 tar-
get [described by Zetsche et al. [24]]. Initially, the crRNA
expression cassettes were prepared as described earlier
[24], by PCR amplification of the human U6 promoter
to which a linker coding the crRNA sequence is ligated
(Fig. 2a) and the modified PCR products were cotrans-
fected along with the corresponding Cpf1 nuclease ex-
pressing vectors (pY010 or pY016 [24], respectively) into
N2a cells. As a result, we were able to detect
fluorescence above the background level in case of both
nucleases; however, this did not seem to be a robust
effect (Fig. 2c). Next, hoping to increase the cleavage
efficiency of the nucleases, the expression cassettes for
both As- and Lb-crRNA – containing the same
DNMT1.3 spacer – were cloned to the corresponding
vectors for nucleases after a human U6 promoter
(Fig. 2b). Here, as well as in later experiments, the trans-
fection efficiency was monitored using a cotransfected
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mCherry expression plasmid. Figure 2c shows that
expressing the crRNAs from plasmid templates results
in 2- to 4-fold increase in GFP positive cells as com-
pared to expression from PCR templates. Thus, plasmids
harbouring both Cpf1 and crRNA expression cassettes
were used in the further experiments.
To facilitate an easier use of these Cpf1 nucleases
against various targets, we cloned the As- and Lb-
crRNAs driven by a human U6 promoter into the pY010
and pY016 plasmids [24], respectively, in such a way that
the 3’ spacer can be precisely inserted between two sites
of a type IIS restriction endonuclease (Esp3I) (Additional
file 4). The created plasmids (pTE4396 for AsCpf1 and
pTE4398 for LbCpf1) are deposited at Addgene (#74041
and #74042, respectively).
As- and LbCpf1 induce efficient repair of the GFP cassette
using homologous sequences
To probe the effectiveness of As- and LbCpf1 nucleases
in inducing SSA repair in mammalian cells, 11 mouse
genomic targets were selected aiming three mouse prion
protein family genes: PRNP, SPRN and PRND (1-11 in
Additional file 2: Table S2). The targets were cloned into
the pGF-ori-FP plasmid and the corresponding spacers
into the AsCpf1- and LbCpf1-plasmids (pTE4396 and
pTE4398, respectively). When tested, both As- and
LbCpf1 effectively induced the repair of the GFP cassette
with all of the 11 targets, resulting more than 10 % fluor-
escent cells in all cases (Fig. 3a). We further probed add-
itional nine target sequences (12–20 in Additional file 2:
Table S2) by both nucleases. All of these targets were also
cleaved efficiently by both nucleases (Fig. 3b), confirming
the robustness of the activity of these Cpf1 nucleases.
Although the utility of As- and LbCpf1 nucleases may be
less than that of SpCas9 they do demonstrate comparable
efficiencies to three other Cas9 nucleases
Except of the promiscuous SpCas9, Cas9s are generally
more selective in their target recognition than the two
Cpf1 nucleases used here are. Several Cas9 nucleases
A
B
Fig. 1 Insertion of a chloramphenicol resistance gene decreases the number of fluorescent cells measured in a GFxFP assay. a Schematic representation
of the interrupted GFP cassette, depicted as on Additional file 1, with a chloramphenicol resistance gene (middle dark grey box) inserted between the
homologous sequences of the GFP halves b The percentages of GFP positive cells are compared when using the reporter assay with either the original
(EGxxFP, green bars) or the additional chloramphenicol resistance gene containing (GF-chl-FP, purple bars) plasmids with the interrupted GFP-halves. In
each case, two targets were tested, PrP10 and Sp1, using SpCas9 nuclease and the corresponding gRNAs along with the reporter plasmids in N2a cells.
As controls, inactive SpCas9 was used in both cases (red bars, dSpCas9). Values are normalized to the transfection efficiencies measured by using the
fluorescence of iRFP670 used as transfection control. Error bars show the mean ± standard deviation of percentages measured in N= 3 independent
transfections. The insertion of the chloramphenicol cassette decreased the number of the fluorescent cells in both the active- and dead SpCas9
containing samples
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AC
B
Fig. 2 Comparison of efficiencies of the Cpf1 nucleases when used with either a PCR- or a plasmid-derived crRNA in N2a mouse neuroblastoma
cells. a Scheme of a plasmid template for nuclease expression (orange: Cpf1 expression cassette) and of a PCR-based template for crRNA expression
[a human U6 promoter PCR product (blue with scarlet forward and reverse primers) with a hybridized dsDNA oligonucleotide (light blue)]. b Scheme of
a dual expression plasmid template for both the nuclease (orange) and the crRNA (light blue) with the human U6 promoter (blue arrow).
c Percentages of GFP positive cells formed above the background level, induced by the nuclease action of either AsCpf1 or LbCpf1. N2a cells
are cotransfected with either a PCR-based template for crRNA and a plasmid for Cpf1 nuclease expression (as depicted on Fig. 2a), labelled as
“PCR”, or with a dual expression plasmid for both the nuclease and the crRNA (as depicted on Fig. 2b), labelled as “plasmid”, respectively. GFP
positive cells are counted two days after transfection by flow cytometry. All samples are also cotransfected by an mCherry expression vector
as a transfection reference and the GFP expression is analysed within the mCherry positive population. The transfection efficiencies measured
based on the fluorescence of mCherry ranged within 55.9 % ± 10.5 % when the plasmid was used, whereas 45.0 % ± 8.4 %, when the PCR
product. As negative control, a crRNA-less, active AsCpf1 nuclease expression vector was used for each target and the obtained levels of GFP
fluorescence for these controls are subtracted from the corresponding samples’ values. Three parallel transfections were made for each case.
Error bars show the mean ± standard deviation of percentages measured in N = 3 independent experiments. Plasmid-expression of the crRNA
results in 2- to 4-fold increase in GFP positive cells as compared to a PCR-template expression
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have been characterised in order to find an orthogonal
counterpart for the most widely used SpCas9 [23]. Here,
we picked three of them, the most frequently considered
ones: from Staphylococcus aureus (SaCas9) [33], from
Streptococcus thermophilus (StCas9) [23, 34], and from
Neisseria meningitidis (NmCas9) [23, 35], and compared
their robustness to those of AsCpf1 and LbCpf1 using
5-5 arbitrary selected targets for each type of nuclease.
The targets were picked randomly, i.e. without employing
any prior knowledge of the sequence specificities of the
nucleases. This was not the case for SpCas9, where we
exploited the existence of gRNA prediction tools: sgRNA
designer [36] and sgRNA scorer 1.0 [37] and accepted
targets scoring above either 0.5 or 50, respectively. In case
of Cpf1 nucleases, representative targets were picked from
the 20 targets used on Fig. 3. All targets were tested with
the GFxFP reporter system (Additional file 1) that allows a
more direct comparison of nuclease activities for inducing
SSA homology directed repair, excluding the possible in-
fluence of the targets’ relative positions to the homologous
arms that is characteristic to HR repair. Interestingly, in
this assay both of the Cpf1 nucleases were equally or more
effective in inducing HDR on average than the three
SpCas9 counterparts: LbCpf1 (24 %) and AsCpf1 (15 %)
versus Sa- (13 %), St- (9 %) or Nm- (3 %) Cas9 (Fig. 4 and
Additional file 5). As expected, SpCas9 exhibited the most
robust activity, although, this might also include a contri-
bution from the prediction tools employed. These results
suggest an important position for the Cpf1 nucleases
beside SpCas9 on the palette of effective genome
A
B
Fig. 3 As- and LbCpf1 nucleases can efficiently cleave randomly picked targets. Percentages of GFP positive cells counted above the background
level, resulted by the action of various nucleases. Eleven randomly picked targets (a) aiming the mouse PRNP (1–4), SPRN (5) and PRND (6–11)
genes and further nine arbitrary targets (b), cloned into the pGF-ori-FP vector were tested using the GFxFP assay. The target vectors along with
the corresponding nuclease vector were transfected into N2a cells and GFP positive cells were counted two days after transfection. All samples
are also cotransfected with an mCherry expression vector to monitor the transfection efficiency and the GFP signal is analysed within the mCherry
positive population. The background fluorescence was estimated by using a crRNA-less, active AsCpf1 nuclease expression vector as negative control,
and the resulting GFP fluorescence found for each target was subtracted from the corresponding sample values. Three parallel transfections were
made for each case. Error bars show the mean ± standard deviation of percentages measured in N = 3 independent transfections. All of these targets
were cleaved efficiently by both nucleases confirming the robustness of the activity of these Cpf1 nucleases
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engineering tools. When a prediction tool is available to
be used for Cpf1 nucleases as well, they might approach
even more the utility of SpCas9 in the future.
Genomic DNA cleavage by As- and LbCpf1 nucleases can
induce efficient HDR
In order to check whether the As- and LbCpf1 nucleases
can effectively induce homology directed repair on some
of the tested targets when these are in their genomic
contexts, we exploited a homologous recombination
donor molecule (pHRdonor-PrP1000) (Tálas et al.,
submitted manuscript). The donor molecule contains a
promoterless GFP open reading frame (ORF) flanked by
1000 bp-long homologous arms to the PRNP gene. Upon
targeted integration, the PrP ORF is replaced by the GFP
ORF, where GFP expression will be driven by the pro-
moter of the PRNP gene. The As- and LbCpf1 plasmids
containing the four crRNAs targeting PRNP used in the
previous experiment (Fig. 3a) were cotransfected with
the donor plasmid and the number of GFP expressing
cells were monitored. Interestingly, transfection of the
promoterless donor plasmid with the inactive dSpCas9
expressing plasmid resulted in some GFP fluorescence
when measured two days after transfection. We used this
transient fluorescent signal hereafter in the experiments
to compare the transfection efficiencies of different sam-
ples using identical donor plasmid. These transient signals
decayed in about six to nine days, after that allowing the
measurement of the GFP signal originating from the
integrated GFP cassettes.
The result on Fig. 5 show that both nucleases mediate
homology directed integration of the donor cassette in
N2a cells. Among the four PRNP targets tested, LbCpf1
cleaved three, whereas AsCpf1 cleaved two targets that
resulted in fluorescence by an order of magnitude higher
than the level of the negative control that corresponds
to the random integration of the donor molecule. We
also found similarly low levels of fluorescence with
controls where the Cpf1 nucleases were cotransfected
with a plasmid containing no corresponding homology
arms (data not shown), indicating that Cpf1’s activity
does not result any significant fluorescence originating
from non-HDR mediated on-target and random integra-
tion. This is likely due to the fact that no promoter
precedes the GFP cassette, thus its integration is silent
unless it becomes integrated downstream of a promoter.
The integration of the donor DNA also depends on
other factors than the nuclease cleavage efficiencies. One
important factor is the position of the target relative to
the homologous arms. This may explain the somehow
lower integration efficiency at site PRNP 4 (number 4 on
Fig. 5) of which position is the most remote from the
homologous arms. Interestingly, LbCpf1 seems to be
slightly more active in this assay mediating integrations
Fig. 4 Lb- and AsCpf1 are equally or more efficient to induce SSA than three tested Cas9 counterparts. Percentages of GFP positive cells counted
above the background level, resulted by the action of various nucleases. Six nucleases were tested, each of them on five different targets using
the GFxFP assay. Columns show the average values obtained for the five different targets in case of each nuclease. GFP positive cells were counted
two days after transfection. All samples were also cotransfected with an mCherry expression vector and the results are analysed within the mCherry
positive population. GFP fluorescence for negative controls was measured using an inactive SpCas9 expressing vector (Tálas et al., submitted
manuscript) and the obtained values are subtracted from each corresponding sample value. Three parallel transfections were made for each case.
Average HDR inducing efficiencies were considered by calculating the average of 15 samples. SpCas9: green, LbCpf1: light green, AsCpf1: yellow,
SaCas9: orange, StCas9: red, NmCas9: scarlet
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two to four fold higher at three out of the four targets
than AsCpf1 (Fig. 5). We found similar integration effi-
ciencies of the same donor plasmid when using Sa- and
StCas9 on a few targets (Additional file 6); however, a
strict comparisons to the Cpf1 nucleases is precluded
due to the different distances of their targets from the
homologous arms that is the consequence of the rare oc-
currences of their 4-5 nucleotide-long PAM sequences.
Our attempts to mediate integration of the donor plas-
mid using NmCas9 with a few targets repeatedly failed.
Discussion
The results presented here significantly extend our know-
ledge on Cpf1 nucleases: these are the first demonstration
that Cpf1 nucleases induce efficient DNA recombination
in mammalian cells based on homologous sequences and
exploring N2a cells – a different cell line – as compared
to human HEK293FT cells used in the pioneering studies
of Zetsche et al. Double strand DNA breaks are generally
repaired by one of the main repair pathways, NHEJ or HR.
The factors affecting the choice between the two pathways
are not fully understood; however, they include both the
types of the DNA break and of the host cells [38]. SpCas9
nuclease has been reported to remain bound to the DNA
target sites after cleavage for an extended period of time
[39] that is likely to significantly affect the choice of repair
pathways. It is not known if Cpf1 nucleases also remain
bound to their DNA substrates after cleavage or not.
Based on the available X-ray structure [25, 27, 40] and on
their cleavage position, it is likely that a Cpf1 nuclease
would not keep the cleaved DNA ends together after
cleavage, even if it remains bound to the DNA. How this
distinct feature of Cpf1 nucleases would affect the repair
pathway choice, it is not known. Nevertheless, our data
show that Cpf1 nucleases are able to induce efficient HR
repair in mammalian cells.
During DNA break repair, SSA and HR repair pathways
are initiated by identical mechanism and are being
separated only after the step of extensive 3’ end resections
of the DNA that also blocks the NHEJ repair pathways
[38, 41]. Although the HR repair pathway, exploiting hom-
ology arms on a donor plasmid is employed more often,
here, the SSA pathways are exploited to interrogate the
activities of Cpf1 nucleases for the following reasons. HR
repair is heavily influenced by the distances of the targets
from the homology arm. To avoid this effect when a num-
ber of nucleases are compared, targets with the corre-
sponding PAM sequences need to be found at nearly
identical genomic positions. However, this is far from
being a trivial task because several of these nucleases
require at least three-nucleotide-long PAM sequences
(As-, LbCpf1, Nm-, Sa-, StCas9). In addition, carrying out
a HR assay takes about nine to fourteen days while
conducting a GFxFP assay requires only four days that
presents advantages.
Our results not only show that the two Cpf1 nucleases
are as or more effective than the most widely used Cas9
counterparts of SpCas9, but also confirm the superior
Fig. 5 As- and LbCpf1 induced HDR at different genomic cleavage sites. Percentages of GFP fluorescent cells after HDR mediated integration
of a promoterless donor GFP cassette. The efficiencies of both As- and LbCpf1 nucleases (orange and blue, respectively) to induce HDR mediated
integration were tested on four mouse PrP genomic targets (PRNP 1-4, same targets as present on Fig. 3a). The nuclease vector and the homologous
recombination donor molecule were cotransfected into N2a cells. As negative control, cells were transfected with the donor molecule and an inactive
SpCas9 expression plasmid. On the seventh day after transfection GFP positive cells were counted. Three parallel transfections were made for each
sample. Two days after transfection all of the samples showed similar GFP positive cell counts. Both Cpf1 nucleases mediated homology directed
integration of the donor cassette in N2a cells
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utility of SpCas9 and the somewhat lower activity of
NmCas9 to that of Sa- and StCas9s. These results are
consistent with our previous characterization of these
Cas9 nucleases (data not shown).
Even more significant is the demonstration of the
robust activity of Cpf1 nucleases in mammalian cells. In
the experiments here (Fig. 3 and Additional file 2: Table
S3), 19 sequences out of the targeted 20 were cleaved ef-
ficiently by both Cpf1 nucleases inducing SSA repair.
The activities of Cas9 nucleases that are characterized so
far vary more widely among various target sequences. A
thorough characterization of Cpf1 nucleases’ target
specificity, like in the case of SpCas9, may further lead
to improve their effectiveness.
Conclusions
While examining only a limited number of target se-
quences, our results suggest that As- and LbCpf1
nucleases, although being less utile than SpCas9 in these
experiments, are able to induce homology directed repair
(SSA and HR) in N2a cells. They demonstrate especially
robust activity to induce SSA in the plasmid-based GFxFP
assay and are equally or more effective than the most fre-
quently used orthogonal Cas9 counterparts of SpCas9.
These results suggest an important position for the Cpf1
nucleases on the palette of effective genome engineering
tools on the side of SpCas9.
Methods
Materials
Restriction enzymes, Klenow polymerase, T4 ligase and
Pfu polymerase were purchased from Thermo Fischer
Scientific. DNA oligonucleotides were acquired from
Microsynth AG [42] or Sigma-Aldrich Co. All DNA con-
structs made were verified by sequencing by Microsynth
AG. Plasmids were purified with GenElute HP Plasmid
Miniprep kit (Sigma-Aldrich). Q5 polymerase was from
New England BioLabs Inc. Dulbecco’s modified Eagle’s
Medium, foetal bovine serum, Turbofect, penicillin and
streptomycin were acquired from Thermo Fisher Scien-
tific. The following plasmids were acquired from Addgene:
piRFP670-N1 #45457 [32]; pX330-U6-Chimeric_BB-CBh-
hSpCas9 #42230 [4]; pCAG-EGxxFP #50716 [31]; pY010
(pcDNA3.1-hAsCpf1) #69982 [24]; pY016 (pcDNA3.1-




Vectors were constructed using standard molecular
biology techniques. For detailed information see
Additional file 7. The sequences of DNA oligonucleo-
tides used in these studies are listed in Additional file 2.
Cell culturing and transfection
N2a cells (Neuro-2a mouse neuroblastoma cells, ATCC –
CCL-131) were grown at 37 °C in a humidified atmosphere
of 5 % CO2 in high glucose Dulbecco’s Modified Eagle
medium (DMEM) supplemented with 10 % heat inacti-
vated fetal bovine serum, 4 mM L-glutamine (Gibco), 100
units/ml penicillin and 100 μg/ml streptomycin.
Details of GFxFP assay
Cells cultured on 48-well plates, were seeded a day
before transfection at a density of 3 × 104 cells/well. The
next day, at around 40 % confluence, cells were trans-
fected with plasmid constructs using Turbofect reagent,
briefly as follows: 250 ng total plasmid DNA and 1 μl
Turbofect were mixed in 50 μl serum free DMEM and the
mixture was incubated for 30 min at room temperature
prior adding to cells. Transfection medium was changed
on the cells to fresh supplemented DMEM after 24 h of
incubation. Three parallel transfections were made from
each sample. A mCherry expression plasmid was cotrans-
fected with each sample to monitor the transfection
efficiency. Cells were analyzed by flow cytometry two days
after transfection.
Details of genomic HDR assay
Cells cultured on 6-well plates were seeded a day before
transfection at a density of 105 cells/well. The next day,
at around 30 % confluence, cells were transfected with
plasmid constructs using Turbofect reagent as follows:
4000 ng total plasmid DNA and 4 μl Turbofect was
mixed in 400 μl serum free DMEM and the mixture was
incubated for 30 min at room temperature prior adding
to cells. Transfection medium on the cells was changed
to fresh supplemented DMEM after 24 h of incubation.
Three parallel transfections were made for each sample.
Two days after transfection, cells were trypsinized and
divided as follows: 10 % of the cells were seeded on new
6-well plates and 90 % of the cells were analyzed by flow
cytometry. Seven days after transfection samples were
measured again by flow cytometry.
Flow cytometry
Flow cytometry analysis was carried out on Attune
Acoustic Focusing Cytometer (Applied Biosystems by
Life Technologies) and on BD FACSCanto II [Becton
Dickinson Immunocytometry Systems]. For data analysis
Attune Cytometric Software was used. In all experi-
ments, a total of 10,000 viable single cells were acquired
and were gated based on side and forward light-scatter
parameters. Cells expressing GFP and mCherry from a
control plasmid were used to identify GFP and mCherry
positive cells in the samples. The GFP signal was
detected using the 488 nm diode laser for excitation and
the 530/30 nm filter for emission. The mCherry signal
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was detected using the 488 nm diode laser for excitation
and a 640LP filter for emission. The signal of iRFP670
(near-infrared fluorescent protein with emission maxima
at 670 nm) was detected using the 633 nm diode laser
for excitation and the 660/20 nm filter for emission.
Reviewers’ comments
Author’s response: We thank all three reviewers for
accepting reviewing our manuscript and for their
comments/recommendations that helped to improve the
manuscript. We also thank all three reviewers for the
thorough reviewing of the text; for spotting typos,
omissions and inaccuracies, that helped us in editing and
improving the manuscript.
Reviewer’s report 1
Eugene Koonin, NCBI, NLM, NIH, USA
Reviewer comments
In the article titled “Cpf1 nucleases demonstrate robust
activity to induce DNA modification by exploiting hom-
ology directed repair pathways in mammalian cells”, Toth
et al describe target cleavage and induction of homology-
directed repair in human cells by two RNA-guided nucle-
ases of the Cpf1 family. The results suggest that both Cpf1
proteins are capable of efficient target cleavage, being ap-
parently less active than the most commonly used SpCas9
but about as active as other characterized Cas9 species.
The work extends the existing knowledge on Cpf1, poten-
tially an important, novel genome editing tool.
The work is somewhat preliminary in the sense that
only two Cpf1 species have been studied, off-target ef-
fects were not assessed, and the comparison to SpCas9
cannot be considered reliable because for SpCas9, the
guide RNA were designed whereas for the rest of the
studied proteins, the guides were chosen randomly. It is
hard to tell why the experiments were done in this non-
uniform manner. It should not be difficult to use
random guides with SpCas9. Without that simple
experiment, the conclusion that Cpf1 is less effective
than SpCas9 does not seem to be quite justified.
Author’s response: The reviewer is right that the work
would be more comprehensive by studying more Cpf1
nucleases. However, Zetsche et al. showed that only these
two Cpf1 species have considerable activity in mamma-
lian (HEK293FT) cells. We agree that it is likely interest-
ing to extend these studies on other Cpf1 species and by
using more kinds of mammalian systems and we plan to
do so.
He is also right in his comment on the differential ways
we selected our targets using prediction tools only for
SpCas9, which makes less fair the comparison of their
natural activities. However, our attempt was different
here. Although the sequence specificity of SpCas9 is not
yet fully understood and the prediction of spacer effi-
ciency is yet at an immature stage at present, SpCas9 is
the only RNA-guided nuclease for which such prediction
tools are available. Contrary, Cpf1 nucleases and the
other Cas9s are much less studied and so far we know
very little about their specificities as compared to
SpCas9. Thus, from a practical point of view when one
needs to decide which nucleases to choose to efficiently
carry out genome modification experiments, currently,
SpCas9 being supported with better spacer prediction
may stand against the use of a Cpf1 nuclease where spa-
cer sequence efficiency selection is not supported yet by
spacer efficiency prediction tools, leaving the only option
of random selection from possible targets. It is this situ-
ation where our experiments might provide valuable
guidance. Nevertheless, when more knowledge is gained
on Cpf1 nucleases based on which spacer efficiency
prediction tools can be built, this issue may need to be
revisited. We discuss and emphasize more this issue,
highlighted by the reviewer, in our revised manuscript.
Reviewer’s report 2
Haruhiko Siomi, Keio University School of Medicine,
Japan
Reviewer comments
Recently Cpf1 has been established as a class 2 CRISPR-
Cas system that includes an effective single RNA-guided
endonuclease (Zetsche et al. Cell 2015). This study com-
pares the single strand annealing (SSA) activity of two
members of the Cpf1 family, the AsCpf1 and the LbCpf1
with that of various Cas9 proteins. The authors find that
both AsCpf1 and LbCpf1 appear to mediate SSA repair
activity more efficiently than three of Cas9 counterparts
do; SaCas9, StCas9 and NmCas9. However, SpCas9
mediates SSA repair more efficiently than the two Cpf1
proteins. These Cpf1 proteins are potentially powerful
tools to edit genomes, but the paper falls short of clearly
demonstrating the usefulness of the SSA activity medi-
ated by Cpf1 proteins.
Major points:
1. The authors should, at least, describe potential
useful features of the SSA mediated by Cpf1 proteins for
genome editing.”
Author’s response: SSA mediated repair can be useful
when direct repeats are to be edited exploiting designer
nucleases, among them Cpf1s. However, our point using
SSA repair here is different. We aim to compare the
ability of Cpf1 and Cas9 nucleases to induce homology
directed repair (HDR), i.e. repair mechanisms based on
homologous sequences involving either homologous
recombination (HR) or single strand annealing (SSA).
During DNA break repair, SSA and HR repair pathways
are initiated by identical mechanism and are being
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separated only after the step of extensive 3’ end resections
of the DNA ends that also block the NHEJ repair pathway.
Thus, the differing ability of Cas9 and Cpf1 nucleases
(emerging from differences in the nature of the double
strand breaks and in their interaction with the target
DNA) to allow the engagement of the repair system for 3’
end resections may be well revealed by monitoring either
the SSA or the HR repair pathways.
Although the HR repair pathway, exploiting hom-
ology arms on a donor plasmid is employed more
often, here, the SSA pathway is also exploited to inter-
rogate the activities of Cpf1 nucleases to induce HDR
for the following reason: HR repair is heavily
influenced by the distances of the targets from the
homology arm. To avoid the contribution of this effect
when two or more nucleases (with different PAM
sequences) are compared, the targets need to be found
at nearly identical genomic positions in relation to the
homology arms. For this, the corresponding PAM
sequences need to be found at nearly identical
positions. However, this is far from being trivial
because several of these nucleases require at least
three to five nucleotide-long PAM sequences (As- and
LbCpf1 three, Nm-, Sa-, StCas9 four to five), which
are rather infrequent.
Nevertheless, we also monitored here how Cpf1 nucle-
ases induce HR repair, although a very strict comparison
cannot be carried out with Cas9s from the above
discussed reasons.
2. The authors shall consider performing experiments
with cleavage-dead Cpf1 in Figs. 3, 4, and 5.
Author’s response: In respect to Figs. 3 and 4 an
active Cpf1 nuclease without crRNA, whereas on Fig. 5 a
dead SpCas9 was used as negative control. We did gener-
ate the corresponding dead As- and LbCpf1 nucleases;
however, at the time the experiments were carried out we
had not characterized them whether they are really fully
inactive or not. Now, we detect no difference between
these three types of controls, dead Cpf1, SpCas9 and
active As- and LbCpf1s without crRNAs, therefore, they
can be used in an interchangeable manner.
3. It seems the authors take the increase in the number
of GFP positive cells as read-out of the increase in the
efficiency of cleavage. But the expression of GFP in their
assay involves cleavage and homologous recombination.
These are in essence totally different steps.
Author’s response: We attempted to discern the
ability of these nucleases to “induce homology directed
repair”. There is no experimental tool currently available
to assess directly the in-cell cleavage activity of a nucle-
ase. The closest equivalent may be the BLESS (direct in
situ breaks labeling, enrichment on streptavidin and
next-generation sequencing) method (N Crosetto et al.,
Nature Methods, 2013) that captures the double strand
breaks that are present at a given moment in the cells.
The “efficiency” of a nuclease is generally inferred based
on detecting the outcome, generally the alteration in the
DNA sequence as a direct result of the cell DNA repair
mechanism that is measured by various readouts. As
such, the cleavage activities may be different than
assessed by relaying on the outcome of different repair
mechanisms. Plausibly, this is the point the reviewer
refers to - and it is the point of the manuscript as well.
We try to assess here the ability of these nucleases to
induce homology directed repair, SSA and HR, contrary
of to induce NHEJ-mediated repair. To avoid confusions,
as pointed by the reviewer, we have changed the wording
of corresponding lines in the manuscript to clarify these
points.
Reviewer’s report 3
Jean-Yves Masson, Universitè Laval, Canada
Reviewer comments
In this manuscript, E. Toth and colleagues aim to
characterize the efficiency of two Cpf1 family members
(AsCpf1 and LbCpf1) in genome engineering. These
nucleases have been characterized previously for indel
frequencies by non-homologous end joining (Zetsche
et al., Cell 163, 759-771). However, their activities on
homology directed repair and single-strand annealing
remained unclear. This is an important question in a fast
growing field where the most efficient tools must be
used for genome engineering. They also used another
cell line, N2a cells, which is different from the studies of
Zetsche et al.
Overall, this nice study suggests that AsCpf1 and
LbCpf1 are alternative tools to Cas9. In fact, they are
more efficient to induce SSA than Cas9 homologs.
Moreover, these nucleases are very efficient, showing
cleavage of 19 out of 20 loci.
Figure 1 and Additional file 1: Figure S1B. It is surprising
that ~ 30 % of the control cells display GFP fluorescence
without any nuclease cleavage. What is the level of en-
dogenous DSBs in the N2a cells? This can be monitored
with immunofluorescence staining with g-H2AX and
53BP1.
Author’s response: This value is actually 10 to 20 %
when the GF-chl-FP constructs are used (Fig. 1b) where
recombination events that possibly occur in Escherichia
coli during plasmid-generation is minimized. Such
background fluorescence obtained in N2a cells can also
be observed at a similar extent in HEK293T and at a
lower extent in HeLa cells (Additional file 3). The higher
fluorescence apparent also after nuclease cleavage may
indicate that the complex process starting from the SSA
repair of the DNA break and extending to the detection
of the fluorescent signal of the expressed GFP protein,
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may somehow more efficiently take place in N2a cells.
However, a contribution from a somewhat higher level of
endogenous DSBs neither can be ruled out, as also
evidenced in Additional file 3.
What is the percentage of cells that are transfected
with mCherry? It is not clear whether SSA is low
because of the transfection efficiency. The transfection
efficiency for each experiment should be shown.
Author’s response: The results that are shown on
Fig. 2c are normalized to the corresponding mCherry
positive population in case of each sample. In the
revised version of the manuscript we added this
information, previously present in the materials and
methods section, to the main text too in order to
clarify this issue. We did a few attempts to increase
the efficiency of the Cpf1 nucleases using the PCR
products, however, without much success. The transfec-
tion efficiencies were relatively similar in these experi-
ments: 55.9 % +/- 10.5 % when the plasmid was used,
whereas 45.0 % +/- 8.4 %, when the PCR product.
Now we indicate these values in the corresponding
figure legend for clarity.
The authors should make a clear distinction between
SSA and HDR. SSA is a RAD52-dependent pathway and
HDR relies mostly on BRCA1-PALB2-BRCA2 and
RAD51. For instance, SSA is monitored in Fig. 4, but the
authors mention in the text that « Cpf1 nucleases were
equally or more effective in inducing HDR on average
than the three SpCas9 counterparts ». This is confusing
with Fig. 5. In Fig. 5, a typical HDR assay is employed
(with an homologous recombination donor). The au-
thors should carefully edit the manuscript to distinguish
SSA assays from HDR assays.
Author’s response: There is some inconsistency in the
literature regarding the terminologies used. We refer as
homology directed repair (HDR) to the repair pathways
that are based on homologous sequences, involving both
homologous recombination (HR) and single strand
annealing (SSA), as it is frequently used in the literature
(A Ciccia and SJ Elledge, Mol Cell, 2010; G Soria and G
Almouzni, Cell Cycle, 2013; F Larminat et al., Oncogene,
2002; M Keimling and L Wiesmüller, Carcinogenesis,
2009). We also noticed papers that use HR and HDR in
the opposite sense [HR involving both HDR and SSA
pathways (SM Howard, DA Yanez and JM Stark, PLoS
Genet, 2015)] or which use other terms, such as conserva-
tive or inter molecular HDR and homology repair [also
denoted as HR, (L Cong et al., Science, 2013)] for the
pathway relying mostly on BRCA1-PALB2-BRCA2 and
RAD51 [as opposed to homologous recombination be-
tween direct repeats (RAD52-dependent]). This is clearly
indicated now at the end of the background section.
Also, in this particular experiment, SaCas9, StCas9
and NmCas9 should be used as controls. This would
help the reviewer to conclude whether they are indeed
better tools for HDR.
Author’s response: We had performed HR experi-
ments with Sa- and StCas9s (results now presented in
Additional File 6); however, the target positions of the
Cas9s generally do not match those of the Cpf1s, which
in our judgment precludes their use for a fair comparison
(relative distance from the cleavage position to the
homology arms might affect the efficiency of homologous
repair-based integration). This was one of the reasons we
preferred to use the GFxFP plasmid system where the in-
frequent presence of the different PAM sequences doesn’t
impede the comparison of the efficiencies of different
nucleases.
To make a more comprehensive study, the authors
should use also integrated reporter cassettes.
Author’s response: We also considered the approach
of using an integrated GFP reporter cassette. Unfortu-
nately, in contrast to SpCas9 having a two nucleotide-long
PAM restriction (GG), Lb- and As-Cpf1 and Sa-, St-and
NmCas9 nucleases have longer, 3 to 5 nucleotide-long
PAM sequences and thus, much less targetable sequences
are available. As a result, Lb- and AsCpf1 (PAM: TTT)
nucleases have only two targets, while StCas9 (PAM:
AGAAW) and NmCas9 (PAM: GATT) have no target in
the GFP reporter construct. Considering mCherry, it has
only one position that has more than two consecutive T
nucleotides. The construction of a new cell line harboring an
integrated reporter cassette of which sequences are altered
in order to contain a reasonable number of PAM sequences
in question was out of the time frame of this study.
They should also make an attempt to discuss off-target
events in light of the two recent studies below:
Daesik Kim, Jungeun Kim, Junho K Hur, Kyung Wook
Been, Sun-heui Yoon & Jin-Soo Kim. Genome-wide ana-
lysis reveals specificities of Cpf1. Nature Biotechnology,
June 2016 doi:10.1038/nbt.3609.
Junho K Hur, Kyoungmi Kim, Kyung Wook Been,
Gayoung Baek, Sunghyeok Ye, Junseok W Hur, Seuk-Min
Ryu, Youn Su Lee & Jin-Soo Kim. Targeted mutagenesis in
mice by electroporation of Cpf1 ribonucleoproteins.
Nature Biotechnology, June 2016 doi:10.1038/nbt.3596.
Author’s response: We included a short discussion
about the fidelity of these Cpf1 nucleases based on the
more recent publications in the Background section.
I acknowledge the spirit of the authors, for deposition
of AsCpf1 and LbCpf1 plasmids at Addgene.
Additional files
Additional file 1: Figure S1. GFxFP reporter assay. (DOCX 766 kb)
Additional file 2: Table S1, Table S2 and Table S3. Oligonucleotide
used in the study. (DOCX 35 kb)
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Additional file 3: Figure S2. The origin of background fluorescence of
GFxFP plasmids. (DOCX 2420 kb)
Additional file 4: Figure S3. Schematic structure of As- (pTE4396) and
LbCpf1 (pTE4398) expression plasmids with crRNA expression cassettes.
(DOCX 99 kb)
Additional file 5: Figure S4. LbCpf1 exert higher efficiency to induce
HDR than three tested Cas9 counterparts. (DOCX 143 kb)
Additional file 6: Figure S5. Homologous recombination of a GFP
casette mediated by St- or SaCas9 at the PRNP locus. (DOCX 13 kb)
Additional file 7: Supplementary Materials and Methods. (DOCX 41 kb)
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